Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Alopecia and acne in women are complex conditions needing coordinated care and personalized treatment.

Polycystic Ovary Syndrome (PCOS) is a complex disorder with both immediate and long-term health effects, including menstrual issues, infertility, and increased risk of diabetes and heart disease.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Eating disorders can cause various hair problems, and while hair loss in these disorders is linked to metabolic syndrome, treatment focuses on specific medications and lifestyle changes for the syndrome.

No link between hair loss and blood groups or Rhesus factor.

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

Alopecia patients have higher heart disease risk; statins and finasteride may help.

11-oxyandrogens are linked to excess hair growth in PCOS, but don't help diagnose it.

Early hair loss in young males may not be clearly linked to insulin resistance or metabolic syndrome.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Cross-sex hormone treatment in transsexual individuals helps understand how sex hormones affect diseases like heart disease and diabetes.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

The document concludes that more research is needed to fully understand the causes of PCOS.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Acupuncture may improve reproductive and metabolic functions in PCOS without negative side effects, but more research is needed to confirm its effectiveness.

PCOS involves microbiome and immune system issues, not just hormones.

PCOS in women from Karnataka is influenced by genetics, family history, and insulin resistance, requiring better diagnosis and treatment.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Women with more body hair tend to have thicker belly fat and more metabolic health issues.